214 related articles for article (PubMed ID: 8382612)
1. Specific phosphopeptide binding regulates a conformational change in the PI 3-kinase SH2 domain associated with enzyme activation.
Shoelson SE; Sivaraja M; Williams KP; Hu P; Schlessinger J; Weiss MA
EMBO J; 1993 Feb; 12(2):795-802. PubMed ID: 8382612
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding.
Piccione E; Case RD; Domchek SM; Hu P; Chaudhuri M; Backer JM; Schlessinger J; Shoelson SE
Biochemistry; 1993 Apr; 32(13):3197-202. PubMed ID: 8384875
[TBL] [Abstract][Full Text] [Related]
3. Regulation of phosphatidylinositol 3'-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit.
Rordorf-Nikolic T; Van Horn DJ; Chen D; White MF; Backer JM
J Biol Chem; 1995 Feb; 270(8):3662-6. PubMed ID: 7876105
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide.
Domchek SM; Auger KR; Chatterjee S; Burke TR; Shoelson SE
Biochemistry; 1992 Oct; 31(41):9865-70. PubMed ID: 1382595
[TBL] [Abstract][Full Text] [Related]
5. SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange.
Felder S; Zhou M; Hu P; Ureña J; Ullrich A; Chaudhuri M; White M; Shoelson SE; Schlessinger J
Mol Cell Biol; 1993 Mar; 13(3):1449-55. PubMed ID: 7680095
[TBL] [Abstract][Full Text] [Related]
6. In vitro association of the phosphatidylinositol 3-kinase regulatory subunit (p85) with the human insulin receptor.
Ottinger EA; Hui TY; Man Z; Barany G; Bernlohr DA
Int J Pept Protein Res; 1995 Nov; 46(5):346-53. PubMed ID: 8567177
[TBL] [Abstract][Full Text] [Related]
7. IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85.
Myers MG; Backer JM; Sun XJ; Shoelson S; Hu P; Schlessinger J; Yoakim M; Schaffhausen B; White MF
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10350-4. PubMed ID: 1332046
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
9. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
Eck MJ; Shoelson SE; Harrison SC
Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
[TBL] [Abstract][Full Text] [Related]
10. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
Bibbins KB; Boeuf H; Varmus HE
Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes.
Nolte RT; Eck MJ; Schlessinger J; Shoelson SE; Harrison SC
Nat Struct Biol; 1996 Apr; 3(4):364-74. PubMed ID: 8599763
[TBL] [Abstract][Full Text] [Related]
12. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.
Case RD; Piccione E; Wolf G; Benett AM; Lechleider RJ; Neel BG; Shoelson SE
J Biol Chem; 1994 Apr; 269(14):10467-74. PubMed ID: 8144631
[TBL] [Abstract][Full Text] [Related]
13. The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor.
Klippel A; Escobedo JA; Fantl WJ; Williams LT
Mol Cell Biol; 1992 Apr; 12(4):1451-9. PubMed ID: 1312663
[TBL] [Abstract][Full Text] [Related]
14. Specificity in recognition of phosphopeptides by src-homology 2 domains.
Cantley LC; Songyang Z
J Cell Sci Suppl; 1994; 18():121-6. PubMed ID: 7533766
[TBL] [Abstract][Full Text] [Related]
15. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav.
Songyang Z; Shoelson SE; McGlade J; Olivier P; Pawson T; Bustelo XR; Barbacid M; Sabe H; Hanafusa H; Yi T
Mol Cell Biol; 1994 Apr; 14(4):2777-85. PubMed ID: 7511210
[TBL] [Abstract][Full Text] [Related]
16. T cell activation-dependent association between the p85 subunit of the phosphatidylinositol 3-kinase and Grb2/phospholipase C-gamma 1-binding phosphotyrosyl protein pp36/38.
Fukazawa T; Reedquist KA; Panchamoorthy G; Soltoff S; Trub T; Druker B; Cantley L; Shoelson SE; Band H
J Biol Chem; 1995 Aug; 270(34):20177-82. PubMed ID: 7544353
[TBL] [Abstract][Full Text] [Related]
17. The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity.
Mulhern TD; Shaw GL; Morton CJ; Day AJ; Campbell ID
Structure; 1997 Oct; 5(10):1313-23. PubMed ID: 9351806
[TBL] [Abstract][Full Text] [Related]
18. Cooperation of Src homology domains in the regulated binding of phosphatidylinositol 3-kinase. A role for the Src homology 2 domain.
Haefner B; Baxter R; Fincham VJ; Downes CP; Frame MC
J Biol Chem; 1995 Apr; 270(14):7937-43. PubMed ID: 7713890
[TBL] [Abstract][Full Text] [Related]
19. Cooperative self-assembly of SH2 domain fragments restores phosphopeptide binding.
Williams KP; Shoelson SE
Biochemistry; 1993 Oct; 32(42):11279-84. PubMed ID: 7692962
[TBL] [Abstract][Full Text] [Related]
20. Phosphopeptide occupancy and photoaffinity cross-linking of the v-Src SH2 domain attenuates tyrosine kinase activity.
Garcia P; Shoelson SE; Drew JS; Miller WT
J Biol Chem; 1994 Dec; 269(48):30574-9. PubMed ID: 7527032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
